Delivery Order SPE2DB20D3101-SPE2DB24FRBF3

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Humira (CF) Pen 40 mg/0.4 mls pharmaceutical products. The contract, valued at $3,523.38, was awarded by the Defense Logistics Agency (DLA) on October 30, 2023, with an ultimate completion date of October 31, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $3,928.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of March 8, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The Delivery Order, valued at $10,633.32, has a firm fixed price and an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $5,541.48, is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA is valued at up to $999,999,999.00 and runs through November 2026, providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Humira(CF) Pen 40 mg/0.4 mls. The contract has a firm fixed price of $8,418.89 and a completion date of May 2, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,357.92 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 22, 2023 and was awarded on August 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,026.09 to supply HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA) Troop Support Medical. The award is issued under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,256.84 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 23, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Humira (CF) Pen 40 mg/0.4 mls. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,284.98 and a completion date of June 21, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRBF3
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Humira (CF) Pen 40 mg/0.4 mL. The contract, valued at $2,770.74, was awarded by the Defense Logistics Agency (DLA) and has a completion date of February 12, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award is a delivery order under that larger IDC, enabling the DLA to efficiently procure essential healthcare commodities for military and veteran healthcare needs. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:42 AM